Michael Freeman

Stock Analyst at Raymond James

(0.04)
# 4,095
Out of 4,789 analysts
1
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Michael Freeman

Bausch Health Companies
Jul 10, 2024
Initiates: Market Perform
Price Target: $8
Current: $6.25
Upside: +28.00%